|4Jan 20, 1:58 PM ET

NeurogesX Inc 4

4 · NeurogesX Inc · Filed Jan 20, 2009

Insider Transaction Report

Form 4
Period: 2009-01-15
Bley Keith R
SVP Nonclinical R & D
Transactions
  • Award

    Employees Stock Option (right to buy)

    2009-01-15+30,00030,000 total
    Exercise: $1.25From: 2009-02-15Exp: 2019-01-15Common Stock (30,000 underlying)
  • Award

    Employees Stock Option (right to buy)

    2009-01-15+28,17228,172 total
    Exercise: $1.25From: 2009-01-15Exp: 2019-01-15Common Stock (28,172 underlying)
Footnotes (2)
  • [F1]One Hundred percent (100%) of the shares subject to the option vest and become exercisable on January 15, 2009.
  • [F2]In connection with 50% of shares subject to option, the achievement of certain performance criteria provides for acceleration of vesting in five equal installments of 20% each. Notwithstanding the acceleration vesting provision, 50% of the option would be 100% vested on January 15, 2015. In connection with the remaining 50% of shares subject to option, the option vests in forty-eight equal monthly installments beginning on February 15, 2009.

Documents

1 file
  • 4
    rrd230388.xmlPrimary

    FORM 4